Cue Biopharma
@cuebiopharma
Developing novel injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body.
ID: 941761021210955777
https://www.cuebiopharma.com/ 15-12-2017 20:04:59
438 Tweet
557 Followers
478 Following
If you’re interested in hearing insights on what’s next for T-cell therapies in oncology, check out FiercePharma’s Angus Liu moderate a discussion of 4 experts, including U.S. FDA’s Dr. Lola Fashoyin & our CEO Dan Passeri on LifeSci Communications’ panel at #BIO24: bit.ly/4cCqUXk